MCRB · Seres Therapeutics, Inc.
$4.54
+0.06 (+1.34%)
At close · Aug 14
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Market Cap
$45.13M
Shares
9.94M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Key facts
CIK
1609809
CUSIP
81750R201
13F (30d)
37 filings
37 filers
Visit website
Investor relations